Information:
Error:
ID
23077
Description
A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00396565
Link
https://clinicaltrials.gov/show/NCT00396565
Keywords
Versions (1)
- 6/22/17 6/22/17 -
Uploaded on
June 22, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenia NCT00396565
Eligibility Schizophrenia NCT00396565
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00396565
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Informed Consent
Item
patients who have given their own consent in writing to participate in the study
boolean
C0021430 (UMLS CUI [1])
Schizophrenia
Item
patients diagnosed with schizophrenia according to the diagnostic criteria of dsm-iv (diagnostic and statistical manual of mental disorders, 295.30, 295.10, 295.20, 295.90, 295.60)
boolean
C0036341 (UMLS CUI [1])
Schizophrenia Symptoms
Item
patients who have acute symptoms of schizophrenia
boolean
C0036341 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,2])
Inpatient | Outpatients
Item
both inpatients and outpatients are acceptable
boolean
C0021562 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
C0029921 (UMLS CUI [2])
Mental disorders | Schizophrenia Excluded
Item
a dsm-iv (diagnostic and statistical manual of mental disorders) of a mental disease diagnosis other than schizophrenia
boolean
C0004936 (UMLS CUI [1])
C0036341 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0036341 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Substance Use Disorders | Nicotine Dependence Excluded | Caffeine dependence Excluded
Item
a dsm-iv diagnosis of substance-related disorder (except nicotine dependence and caffeine dependence) within 180 days before the screening test
boolean
C0038586 (UMLS CUI [1])
C0028043 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C1386553 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
C0028043 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C1386553 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
Positive and negative syndrome scale
Item
total panss (positive and negative syndrome system) score at the screening test <70 or >120
boolean
C0451383 (UMLS CUI [1])
Antipsychotic Agents Type Quantity
Item
patients treated with three or more types of antipsychotic within 28 days before the screening test
boolean
C0040615 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0332307 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Parkinson Disease | Extrapyramidal symptoms Drug-induced Excluded
Item
parkinson's disease (except for those with drug-induced extra pyramidal symptoms)
boolean
C0030567 (UMLS CUI [1])
C0234133 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
C2828389 (UMLS CUI [2,3])
C0234133 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
C2828389 (UMLS CUI [2,3])
Cerebrovascular accident Complication
Item
patients with a complication of or a past history of cerebrovascular accident
boolean
C0038454 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C0009566 (UMLS CUI [1,2])
Complications of Diabetes Mellitus
Item
patients with a complication of or a past history of diabetes mellitus
boolean
C0342257 (UMLS CUI [1])